Levonorgestrel And Ethinyl Estradiol Kit
Product Images NDC 42192-623

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levonorgestrel And Ethinyl Estradiol (NDC 42192-623). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Acella Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structures (Image 01)

Chemical structure of the active ingredients levonorgestrel and ethinyl estradiol. The image shows each compound's molecular formula and molecular weight: levonorgestrel (C21H28O2, MW 312.4) and ethinyl estradiol (C20H24O2, MW 296.4).*

FDA Label Image

Figure 2 (Image 02)

Two line graphs showing concentration (pg/mL) of levonorgestrel and ethinyl estradiol over time (hours). Both graphs display a rapid decrease in concentration from 0 to 24 hours, followed by a gradual decline up to 96 hours. Error bars indicate variability at various time points.*

FDA Label Image

How Does Balcoltra Work For Contraception (Image 03)

An illustration showing a vertical arrow labeled with pregnancy rates per 100 women in one year, ranging from fewer than 1 to 85 or more pregnancies. It categorizes contraceptive methods into groups based on their effectiveness, including implants, injections, intrauterine devices, and sterilization at the most effective end; birth control pills, skin patch, and vaginal ring with hormones as moderately effective; condoms and diaphragm as less effective; spermicide, withdrawal, and avoiding sex during fertile days as low effectiveness; and no birth control at the least effective.*

FDA Label Image

Instructions For Use (Figure 1)

Levonorgestrel and ethinyl estradiol kit containing a weekly blister pack of oral tablets organized by day from Sunday to Saturday. The pills are color-coded with orange and blue tablets, and arrows indicate the direction to take pills from left to right each week. Labeler shown is Acella Pharmaceuticals.*

FDA Label Image

Instructions For Use (Figure 2)

An instructional illustration showing a hand peeling back the foil of a birth control pill blister pack. The pack contains 28 pills arranged in rows labeled with days of the week, with orange and blue pills indicating different types. Arrows guide the user to take pills from left to right each week, starting on Monday.*

FDA Label Image

Principal Display Panel (Carton Front)

Levonorgestrel and Ethinyl Estradiol Tablets, USP and Ferrous Bisglycinate Tablets 0.1 mg/0.02 mg and 36.5 mg kit by Acella Pharmaceuticals. The packaging is for a 28-day regimen blister pack containing 28 tablets. The label includes a warning that the product is intended to prevent pregnancy but does not protect against HIV/AIDS or other sexually transmitted diseases. Marked Rx Only.*

FDA Label Image

Principal Display Panel (Carton Back)

Drug Facts and usage instructions panel for a kit containing levonorgestrel and ethinyl estradiol tablets, USP, and ferrous bisglycinate tablets. The kit includes a 28-day regimen with 28 tablets: 21 orange tablets each containing 0.1 mg levonorgestrel and 0.02 mg ethinyl estradiol, and 7 blue tablets containing ferrous bisglycinate 36.5 mg. The panel includes storage conditions, warnings about accidental overdose, and manufacturer information for Acella Pharmaceuticals.*

FDA Label Image

Acella (Image 08)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.